MRC – Medical Research Council Protein Phosphorylation and Ubiquitylation Unit
The MRC-PPU is one of the world’s most renowned centres for research on protein phosphorylation and ubiquitylation (http://www.ppu.mrc.ac.uk/). Many world leading researchers in the field of signal transduction have trained within the MRC-PPU. The major aims of the MRC-PPU are to advance understanding of the role of protein phosphorylation and ubiquitylation in cell regulation and human disease, to facilitate the development of drugs to treat diseases caused by abnormalities in phosphorylation, to generate reagents and improve technologies.
Summary of Skills, Experience and Qualifications
• Capable of both working as part of a small team and independently.
• Able to multitask routinely using excellent time management in a potentially highly repetitive role with time sensitive processes
• Lab experience highly desirable
• Excellent communication skills and knowledge of the English language are essential.
• Knowledge of DNA sequencing and/or Fragment analysis would be advantageous
The position is initially available until March 2019 with the intention of renewal
The position will be on the University's Grade 4 (£18777 to £21585 per annum).
College / School / Directorate Information
Division of Signal Transduction Unit:
The Division of Signal Transduction Therapy (DSTT) was established in 1998. This division operates as a unique collaboration between scientists in the MRC-PPU (all PIs including Ronald Hay FRS Honorary PI of MRC-PPU) and signalling researchers at the University's School of Life Sciences (Simon Arthur, Doreen Cantrell FRS, Alessio Ciulli, Paul Crocker, Grahame Hardie FRS and Carol MacKintosh) and three leading pharmaceutical companies (Boehringer Ingelheim, GlaxoSmithKline, Merck Serono). The DSTT is widely regarded as a model for how academia should interact with industry, The DSTT operates as a simple bridging mechanism to enable our PIs working on ubiquitylation and phosphorylation to effectively interact with three major pharmaceutical companies to help accelerate the early stages of drug discovery. The DSTT model enables industrial researchers working in any of the worldwide outlets of three pharmaceutical companies to effectively work with the ~200 Dundee-based researchers that participate in the collaboration to understand the fundamentals of the molecular causes of disease that result from disruptions in protein phosphorylation and ubiquitylation networks.
The University is a diverse community and is committed to equality of opportunity for all by providing a supportive, flexible and inclusive working environment. We have family friendly policies (including flexible working and childcare vouchers), staff groups for LGBT and BME; and prayer room facilities.
The University has received the Athena SWAN Bronze Award (Athena Swan) which recognises the promotion of gender equality and has made further commitment to advancing inclusive culture which supports and encourages all under-represented groups.
The University of Dundee is a Scottish Registered Charity, No. SC015096.